Laurie Keating

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Kalaris Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get KLRS alerts

About Laurie Keating

Laurie Keating is recorded as Board Member at Kalaris Therapeutics, Inc. (KLRS) since August 1, 2026. Kalaris Therapeutics, Inc. reported in an 8-K filed July 6, 2026 that Laurie Keating was appointed member of the Board, effective August 1, 2026. Kalaris Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kalaris Therapeutics, Inc. includes Andrew Oxtoby (CEO and Board Member), Diana M. Brainard (CEO and Board Member), Vikas Sinha (CEO) and 7 others.

“On July 3, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board elected Laurie Keating to serve as a member of the Board, effective as of August 1, 2026.”

Kalaris Therapeutics, Inc. Form 8-K, filed July 6, 2026 · Read the filing

Affiliation history

Kalaris Therapeutics, Inc. (KLRS)
Board Member

SEC 8-K

Current
2026-08-01–present

Company network

Kalaris Therapeutics, Inc.

KLRS

Current role

Biotechnology · Healthcare

Board Member

2026-08-01–present

Leadership on record at Kalaris Therapeutics, Inc.

Andrew Oxtoby CEO, Board Member
Diana M. Brainard CEO, Board Member
Vikas Sinha CEO
David Hallal Chairman, Board Member
Brett Hagen CFO
Liisa Bayko CFO
Matthew Gall CFO
Amy Vandekop Chief Accounting Officer
Anthony Adamis Board Member
Derek Adams, Ph.D. Board Member

Recent activity

Executive change Appointed: member of the Board Kalaris Therapeutics, Inc. (KLRS)
2026-08-01